RenovoRx, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.9M | $-3.5M | $-2.9M | $-2.9M | $-2.9M | $-2.4M | $-2.9M | $-2.5M |
| Depreciation & Amortization | — | $1.0K | — | $1.0M | $1.0M | — | — | — |
| Depreciation | $5.0K | $1.0K | $1.0K | $-1.0K | $1.0K | $1.0K | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $570.0K | $317.0K | $285.0K | $349.0K | $345.0K | $288.0K | $252.0K | $255.0K |
| Net Cash from Operating Activities | $-2.9M | $-3.7M | $-3.0M | $-2.3M | $-2.3M | $-3.4M | $-2.4M | $-2.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $71.0K | $0 | $0 | $0 | $0 | $2.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-71.0K | $0 | $0 | $0 | $0 | $-2.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $55.0K | $9.0M | $0 | $0 | $34.0K | $10.8M | $33.0K | $15.0K |
| Net Change in Cash | $-2.9M | $5.3M | $-3.0M | $-2.3M | $-2.3M | $7.4M | $-2.4M | $-2.2M |
| Free Cash Flow | $-2.9M | $-3.7M | $-3.0M | $-2.3M | $-2.3M | $-3.4M | — | — |